Learn more

ETHICON INCORPORATED

Overview
  • Total Patents
    50
  • GoodIP Patent Rank
    177,899
  • Filing trend
    ⇧ 50.0%
About

ETHICON INCORPORATED has a total of 50 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2004. It filed its patents most often in Australia, Mexico and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are CELLERIX SL, BECKER DAVID L and CODA THERAPEUTICS INC.

Patent filings in countries

World map showing ETHICON INCORPORATEDs patent filings in countries
# Country Total Patents
#1 Australia 19
#2 Mexico 19
#3 Canada 6
#4 EPO (European Patent Office) 4
#5 China 2

Patent filings per year

Chart showing ETHICON INCORPORATEDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Messina Darin J 16
#2 Kihm Anthony J 12
#3 Seyda Agnieszka 11
#4 Gosiewska Anna 11
#5 Harmon Alexander M 10
#6 Mistry Sanjay 10
#7 Kramer Brian C 9
#8 Harris Ian Ross 7
#9 Yi Chin-Feng 6
#10 Romanko Michael J 5

Latest patents

Publication Filing date Title
MX2014011101A Devices for dispensing surgical fasteners into tissue while simultaneously generating external marks that mirror the number and location of the dispensed surgical fasteners.
AU2011226961A1 Regeneration and repair of neural tissue using postpartum-derived cells
AU2011226863A1 Regeneration and repair of neural tissue using postpartum-derived cells
AU2011226836A1 Treatment of parkinson's disease and related disorders using postpartum derived cells
CA2747758A1 Regeneration and repair of neural tissue following injury
EP2231209A2 Encapsulated kidney tissue
CA2589041A1 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
CA2592435A1 Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
AU2004252571A1 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system